From Our Blog

More from the blog »
Global Network

Prevention of hepatocellular carcinoma by EGCG (2012)


Prevention of hepatocellular carcinoma by EGCG

Key words:

Research Institution:

Massachusetts General Hospital (The General Hospital Corp.)




Bryan Fuchs

Project Description:

Dr. Fuchs is using an animal model of chronic liver disease to determine whether EGCG (a phytochemical in green tea), inhibits the development of liver cancer by inhibiting cirrhosis. He is testing EGCG alone and in combination with erlotinib, a common treatment for the disease, to determine if it slows tumor progression.

Cancer Site(s)

Related Foods that Fight Cancer

Questions: Ask Our Staff

Talk to us!

Our planned giving staff is
here to help you!

Ann Wrenshall Worley

Ann Wrenshall Worley

Assistant Director of Planned Giving

Call Us: (800) 843-8114

Send us a note